// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Race and Gender Differences in Mortality From Atrial Fibrillation in the United States: 1999 to 2018

Arshi Parvez - American Heart Association (AHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arrhythmia

N/A

Association Between Adrenergic Receptor Modulation and the Risk of Heart Failure: A Two-sample Mendelian Randomization Study

Claire Baudier - American Heart Association (AHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Congestive heart failure

N/A

A Novel Genetic Risk Score Predicts Ischemic Stroke in Patients With Cardiometabolic Disease

Parth N Patel - American Heart Association (AHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Congestive heart failure

N/A

Shared Genetic Pathways Contribute to Risk of Hypertrophic and Dilated Cardiomyopathies With Opposite Directions of Effect

Rafik Tadros - American Heart Association (AHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Cardiovascular Outcomes in Patients With Established Atherosclerosis and LDLR Loss of Function: Results From the FOURIER Trial

Nicholas A Marston - American Heart Association (AHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

N/A

De Novo Variants of USP10 in Early Onset Bicuspid Aortic Valve Disease

Siddharth K Prakash - American Heart Association (AHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Bicuspid aortic valve

N/A

Analysis of Survival in Octogenarian and Nonagenarian Patients Treated With Primary Percutaneous Coronary Intervention for ST Elevation Myocardial Infarction

Aaruni Saxena - American Heart Association (AHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

N/A

Ischaemic Pre-conditioning: A Non-invasive Intervention That Improves Maternal Endothelial Function in Women With Preeclampsia And at Risk of Preeclampsia

Tamara Kubba - American Heart Association (AHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Preeclampsia

N/A

Pericardial Tamponade in Patients With Influenza Infection: A Systematic Review of Published Cases

Rupak Desai - American Heart Association (AHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Cardiac tamponade

N/A

Pericardial Complications in Patients With COVID-19: A Systematic Review of Published Cases

Sandeep Singh - American Heart Association (AHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Cardiac tamponade

N/A

Clinical Importance of Left Atrial Infiltration in Cardiac Transthyretin Amyloidosis

Francesco Bandera - American Heart Association (AHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Transthyretin cardiac amyloidosis

N/A

Venous complication of Behçet's: internal jugular vein thrombosis

Kaushik Sanyal - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

N/A

Bywaters still runs deep in rheumatology: adult onset Still’s disease case series

Raj Amarnani - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Adult onset Still's disease

N/A

Transformation of reactive arthritis into psoriatic spondyloarthritis

Karina Lazarewicz - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Spondyloarthritis

Sulfasalazine

Patterns of the patient acceptable symptom state over 12 months following the initiation of methotrexate therapy in patients with rheumatoid arthritis, and the association between these patterns and disability and disease activity

James Gwinnutt - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Methotrexate

A study to investigate whether if any barriers in ethnic minority patients may impact on research participation in a district general hospital

Vanesha Ramasamy - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Re-visiting and re-invigorating a rheumatology-led ultrasound service in a large urban district general hospital

Rachel X N Lee - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The use of musculoskeletal ultrasound in new outpatient management: experience from a single centre

Bilal M A Alam - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Predictors of osteoporotic fractures in men: a retrospective review of DEXA scans at Royal Preston Hospital

Susan F King - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoporosis

N/A

Vitamin D associated single nucleotide polymorphisms are associated with bone mass and microarchitecture in later life: findings from the Hertfordshire Cohort Study

Laetitia H Lloyd-Davies - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Ergocalciferol

Copyright © 2026. QuantiNova All rights reserved